<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="nucleoside analog drugs targeting specific viral polymerases (acyclovir for herpesviruses," exact="zidovudine" post="for human immunodeficiency virus (HIV), and sofosbuvir for hepatitis"/>
 <result pre="(acyclovir for herpesviruses, zidovudine for human immunodeficiency virus (HIV), and" exact="sofosbuvir" post="for hepatitis C virus (HCV)) have been successful in"/>
 <result pre="IFN-α [6]. Importantly, extensive studies on the antiviral action of" exact="ribavirin" post="have established the underlying molecular framework of nucleoside analogs."/>
 <result pre="EV71 [18]. As previously mentioned, the combination of gemcitabine with" exact="decitabine" post="synergistically suppressed HIV infectivity both in vitro and in"/>
 <result pre="as summarized in Table 2 [6,10,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42]. Regarding purine biosynthesis inhibitors," exact="ribavirin" post="and mycophenolic acid (MPA) are inhibitors of inosine-5′-monophosphate (IMP)"/>
 <result pre="in Table 2 [6,10,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42]. Regarding purine biosynthesis inhibitors, ribavirin and" exact="mycophenolic acid" post="(MPA) are inhibitors of inosine-5′-monophosphate (IMP) dehydrogenase (IMPDH), which"/>
 <result pre="the stimulation of ISGs [10,30]. For the antiviral activity of" exact="ribavirin" post="against HCV, ribavirin specifically induced the expression of IRF7,"/>
 <result pre="ISGs [10,30]. For the antiviral activity of ribavirin against HCV," exact="ribavirin" post="specifically induced the expression of IRF7, IRF9, and ISG15"/>
 <result pre="classical JAK/STAT system, which is similar to that observed with" exact="ribavirin" post="[30]. Similar results were obtained with several IMPDH1 or"/>
 <result pre="was not mediated by JAK [10]. Second, IRF7 induction by" exact="ribavirin" post="was not affected by knockdown of STAT1, while that"/>
 <result pre="classical IFN signal in the activation of ISGs induced by" exact="ribavirin" post="[6]. Despite the consensus of ISG activation, each purine/pyrimidine"/>
 <result pre="signaling pathway involved. The synergistic antiviral activity of gemcitabine and" exact="ribavirin" post="observed in our study might be explained by the"/>
 <result pre="Rev. Drug Discov.20131244746410.1038/nrd401023722347 2.ElionG.B.The purine path to chemotherapyScience1989244414710.1126/science.26499792649979 3.WhitleyR.J.AlfordC.A.HirschM.S.SchooleyR.T.LubyJ.P.AokiF.Y.HanleyD.NahmiasA.J.SoongS.J.Vidarabine versus" exact="acyclovir" post="therapy in herpes simplex encephalitisN. Eng. J. Med.198631414414910.1056/NEJM1986011631403033001520 4.KahnJ.O.LagakosS.W.RichmanD.D.CrossA.PettinelliC.LiouS.H.BrownM.VolberdingP.A.CrumpackerC.S.BeallG.et"/>
 <result pre="encephalitisN. Eng. J. Med.198631414414910.1056/NEJM1986011631403033001520 4.KahnJ.O.LagakosS.W.RichmanD.D.CrossA.PettinelliC.LiouS.H.BrownM.VolberdingP.A.CrumpackerC.S.BeallG.et al.A controlled trial comparing continued" exact="zidovudine" post="with didanosine in human immunodeficiency virus infection. The niaid"/>
 <result pre="J. Med.198631414414910.1056/NEJM1986011631403033001520 4.KahnJ.O.LagakosS.W.RichmanD.D.CrossA.PettinelliC.LiouS.H.BrownM.VolberdingP.A.CrumpackerC.S.BeallG.et al.A controlled trial comparing continued zidovudine with" exact="didanosine" post="in human immunodeficiency virus infection. The niaid aids clinical"/>
 <result pre="virus cell culture modelsHepatology201153324110.1002/hep.2398521254160 7.LeyssenP.BalzariniJ.de ClercqE.NeytsJ.The predominant mechanism by which" exact="ribavirin" post="exerts its antiviral activity in vitro against flaviviruses and"/>
 <result pre="17.ClouserC.L.HoltzC.M.MullettM.CrankshawD.L.BriggsJ.E.O’SullivanM.G.PattersonS.E.ManskyL.M.Activity of a novel combined antiretroviral therapy of gemcitabine and" exact="decitabine" post="in a mouse model for HIV-1Antimicrob. Agents Chemother.2012561942194810.1128/AAC.06161-1122271861 18.KangH.KimC.KimD.E.SongJ.H.ChoiM.ChoiK.KangM.LeeK.KimH.S.ShinJ.S.et"/>
 <result pre="HIV-1Antimicrob. Agents Chemother.2012561942194810.1128/AAC.06161-1122271861 18.KangH.KimC.KimD.E.SongJ.H.ChoiM.ChoiK.KangM.LeeK.KimH.S.ShinJ.S.et al.Synergistic antiviral activity of gemcitabine and" exact="ribavirin" post="against enterovirusesAntivir. Res.201512411010.1016/j.antiviral.2015.10.01126526589 19.BeranR.K.SharmaR.CorsaA.C.TianY.GoldeJ.LundgaardG.DelaneyW.E.t.ZhongW.GreensteinA.E.Cellular growth kinetics distinguish a cyclophilin"/>
 <result pre="cultured mammalian cellsAntivir. Res.2011891810.1016/j.antiviral.2010.10.00921070810 27.TakhampunyaR.UbolS.HoungH.S.CameronC.E.PadmanabhanR.Inhibition of dengue virus replication by" exact="mycophenolic acid" post="and ribavirinJ. Gen. Virol.2006871947195210.1099/vir.0.81655-016760396 28.YingC.ColonnoR.de ClercqE.NeytsJ.Ribavirin and mycophenolic acid"/>
 <result pre="by mycophenolic acid and ribavirinJ. Gen. Virol.2006871947195210.1099/vir.0.81655-016760396 28.YingC.ColonnoR.de ClercqE.NeytsJ.Ribavirin and" exact="mycophenolic acid" post="markedly potentiate the anti-hepatitis B virus activity of entecavirAntivir."/>
 <result pre="activity of entecavirAntivir. Res.20077319219610.1016/j.antiviral.2006.10.00317098296 29.WangY.ZhouX.DebingY.ChenK.van der LaanL.J.NeytsJ.JanssenH.L.MetselaarH.J.PeppelenboschM.P.PanQ.Calcineurin inhibitors stimulate and" exact="mycophenolic acid" post="inhibits replication of hepatitis E virusGastroenterology20141461775178310.1053/j.gastro.2014.02.03624582714 30.PanQ.de RuiterP.E.MetselaarH.J.KwekkeboomJ.de JongeJ.TilanusH.W.JanssenH.L.van"/>
 <result pre="in vitro and in vivoHepatology2012551673168310.1002/hep.2556222213147 31.PanattoniA.D’AnnaF.TrioloE.Antiviral activity of tiazofurin and" exact="mycophenolic acid" post="against grapevine leafroll-associated virus 3 in vitis vinifera explantsAntivir."/>
 <result pre="vitis vinifera explantsAntivir. Res.20077320621110.1016/j.antiviral.2006.10.00717125850 32.ShirakiK.IshibashiM.OkunoT.KokadoY.TakaharaS.YamanishiK.SonodaT.TakahashiM.Effects of cyclosporine, azathioprine, mizoribine, and" exact="prednisolone" post="on replication of human cytomegalovirusTransplant. Proc.199022168216852167528 33.FurutaY.TakahashiK.FukudaY.KunoM.KamiyamaT.KozakiK.NomuraN.EgawaH.MinamiS.WatanabeY.et al.In vitro"/>
 <result pre="cultureAntimicrob. Agents Chemother.2010543686369510.1128/AAC.00561-1020606073 35.SchlapferE.FischerM.OttP.SpeckR.F.Anti-HIV-1 activity of leflunomide: A comparison with" exact="mycophenolic acid" post="and hydroxyureaAIDS2003171613162010.1097/00002030-200307250-0000512853743 36.FarasatiN.A.ShapiroR.VatsA.RandhawaP.Effect of leflunomide and cidofovir on replication"/>
 <result pre="leflunomide: A comparison with mycophenolic acid and hydroxyureaAIDS2003171613162010.1097/00002030-200307250-0000512853743 36.FarasatiN.A.ShapiroR.VatsA.RandhawaP.Effect of" exact="leflunomide" post="and cidofovir on replication of BK virus in an"/>
 <result pre="comparison with mycophenolic acid and hydroxyureaAIDS2003171613162010.1097/00002030-200307250-0000512853743 36.FarasatiN.A.ShapiroR.VatsA.RandhawaP.Effect of leflunomide and" exact="cidofovir" post="on replication of BK virus in an in vitro"/>
 <result pre="[34] [10] Mizoribine IMPDH, GMP synthetase [32] LeflunomideTeriflunomide DHODH [35,36]" exact="Ribavirin" post="IMPDH [6,26,27,28] [6] 6-Azauridine ODCase [10,25,26] [10] Favipiravir (T-705)"/>
</results>
